RevaTis
ActiveSummary
RevaTis has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.6m and a net result of -€620,715. Equity is growing by about 14% per year across the filed financial years. Its solvency ranks better than 75% of 60 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
17-07
Gazette deed
Appointments: SERTEYN Didier Daniel Alex (director) and MARTIN Jean-Luc (director)Power of attorney · Capital increase · Share issue14 facts ▸
- General meeting, “Assemblée générale extraordinaire” (deed in French)
- Director appointment, SERTEYN Didier Daniel Alex (director)
- Director appointment, MARTIN Jean-Luc (director)
- Board meeting, 30-03-2026
- Board meeting, 26-05-2025
- Power of attorney, SERTEYN Didier Daniel Alex
- Power of attorney, MARTIN Jean-Luc
- Capital increase, €17,000
- Other provision, “Suppression du droit de préférence, augmentation de capital en numéraire” (deed in French)
- Share issue, “souscription et libération, augmentation de capital en numéraire” (deed in French)
- Capital, €1,450,000
- Other provision, “Affectation en un compte indisponible « Prime d’émission », Prime d’émission” (deed in French)
- +2 further facts in this act
30-10
Gazette deed
Resignations: Claude Dedry, Alexandre Dallemagne and 4 othersAppointment: NOSHAQ PARTNERS (director) · Permanent representative: Eric Brandt · Approval21 facts ▸
- General meeting, 13-06-2025
- Approval, “rapport d'activité et de gestion du Conseil d'Administration, approuvé” (deed in French)
- Approval, “comptes 2024, présentés et approuvés” (deed in French)
- Other provision, “poursuite des activités, approuvée” (deed in French)
- Director resignation, Claude Dedry (director)
- Director resignation, Alexandre Dallemagne (director)
- Director resignation, Jean-Claude Havaux (director)
- Director resignation, Natascha Holper (director)
- Director resignation, Jacques Kuypers (director)
- Director resignation, Philippe Neven (director)
- Director appointment, NOSHAQ PARTNERS (director)
- Permanent representative, Eric Brandt
- +9 further facts in this act
23-09
Gazette deed
Capital & sharesDirector in office · Capital increase · Capital12 facts ▸
- General meeting, 05-09-2025
- Director in office, SERTEYN Didier Daniel Alex (director)
- Director in office, MARTIN Jean-Luc (director)
- Board meeting, 15-03-2025
- Board meeting, 27-01-2025
- Capital increase, €34,000
- Other provision, “Suppression du droit de préférence” (deed in French)
- Other provision, “Souscription à l’augmentation de capital en numéraire et libération des actions nouvelles” (deed in French)
- Capital, €1,433,000
- Other provision, “Affectation en un compte indisponible « Prime d’émission »” (deed in French)
- Amendment of the articles, “5§1” (deed in French)
- Power of attorney
22-04
Gazette deed
Capital & shares · Resignations & appointmentsDirector in office · Power of attorney · Capital increase13 facts ▸
- General meeting, “REVATIS, Assemblée générale extraordinaire” (deed in French)
- Director in office, SERTEYN Didier Daniel Alex (director)
- Director in office, KUYPERS Jacques Guillaume Marie Henri (director)
- Board meeting, 27-01-2025
- Board meeting, 15-03-2025
- Power of attorney, SERTEYN Didier Daniel Alex
- Power of attorney, KUYPERS Jacques Guillaume Marie Henri
- Capital increase, €92,000
- Other provision, “suppression du droit de préférence, omitted” (deed in French)
- Other provision, “souscription à l'augmentation de capital en numéraire et libération des actions nouvelles, omitted” (deed in French)
- Capital, €1,399,000
- Other provision, “affectation en un compte indisponible Prime d'émission, omitted” (deed in French)
- +1 further fact in this act
27-01
Gazette deed
Capital & sharesBoard composition · Transfer of a branch of activity or universality · Share issue73 facts ▸
- Board meeting, 16-12-2024 (2 times)
- Board composition, Didier SERTEYN (director)
- Board composition, JosephMartial (director)
- Board composition, PhilippeNeven (director)
- Board composition, Jean-ClaudeHavaux (director)
- Board composition, Jean-LucMartin (director)
- Board composition, JacquesKuypers (director)
- Board composition, Jean-LoupBlondeau (director)
- Board composition, FrédéricBoeckx (director)
- Other provision, “ordred jour, réalisationeffectivedelapportdebranchedactivitéen nature” (deed in French)
- Other provision, “pointsàlordred jour, conflitsdintérêts” (deed in French)
- Transfer of a branch of activity or universality, “branch of activity, greffeTribunaldelentreprisedeMarche-en-Famenne” (deed in French)
- +61 further facts in this act
22-11
Gazette deed
Resignations & appointmentsIncorporation · Capital · Transfer of a branch of activity or universality10 facts ▸
- Incorporation, 31-10-2013
- Capital, €1,307,000
- Transfer of a branch of activity or universality, “branch of activity, commercialisation de produits de médecine régénérative vétérinaire et la R&D y afférente en biotechnologie vétérinaire «AH Com et AH R&D non…” (deed in French)
- Other provision, “jouissance des actions attribuées, selon les modalités et dans les limites prévues dans les statuts” (deed in French)
- Accounting effect, 01-07-2024
- Other provision, “avantages particuliers aux administrateurs” (deed in French)
- Transfer of a branch of activity or universality, “branch of activity, commercialisation de produits de médecine régénérative vétérinaire et R&D y afférente en biotechnologie vétérinaire «AH Com et AH R&D non su…” (deed in French)
- Other provision, 30-06-2024, “situation comptable au 30-06-2024 et répartition” (deed in French)
- Other provision, “précisions sur éléments transférés, uniquement provision facture à recevoir production immobilisée S1 2024 AH-R&D hors convention” (deed in French)
- Other provision, “droits et engagements hors bilan, Néant” (deed in French)
Show earlier events
About the unread acts
Of the 26 Belgian Official Gazette deeds we know for this company, 6 have been read. The other 20 have not been read yet: what they contain is neither established nor disproved here.